Results 211 to 220 of about 5,917,592 (236)

CA19-9 decrease at 8 weeks as a predictor of overall survival in a randomized phase III trial (MPACT) of weekly nab-paclitaxel plus gemcitabine versus gemcitabine alone in patients with metastatic pancreatic cancer

Annals of Oncology, 2016
David Goldstein, Josep Tabernero Caturla, Reni Michele   +2 more
exaly  

CA19-9

2006
openaire   +1 more source

ANTI-CA19-9 ANTIBODY, APPLICATION THEREOF, AND KIT FOR DETECTING CA19-9

2022
CUI PENG, HE ZHIQIANG, MENG YUAN, ZHONG DONGMEI, LOU WENJUAN, QIN TING, FAN LINGYUN   +6 more
openaire   +1 more source

Implications of CA19-9 elevation for survival, staging, and treatment sequencing in intrahepatic cholangiocarcinoma: A national cohort analysis

Journal of Surgical Oncology, 2016
Lewis R. Roberts, Rory L Smoot, Elizabeth B Habermann   +2 more
exaly  

The Clinical Utility and Limitations of Serum Carbohydrate Antigen (CA19-9) as a Diagnostic Tool for Pancreatic Cancer and Cholangiocarcinoma

Digestive Diseases and Sciences, 2011
Luis Lara, Shou-Jiang Tang, Jayaprakash Sreenarasimhaiah   +2 more
exaly  

Serum CA19-9 Abnormal

2020
openaire   +1 more source

Serum Levels of CA19-9 in patients with nonmalignant respiratory diseases

Journal of Clinical Laboratory Analysis, 2007
Hiroaki Satoh, Hiroichi Ishikawa, Takahide Kodama   +2 more
exaly  

CA19-9 Level Finding

2020
openaire   +1 more source

CA19-9 serum levels in obstructive jaundice: clinical value in benign and malignant conditions

American Journal of Surgery, 2009
Alessandro Neri, Daniele Marrelli, Corrado Pedrazzani   +2 more
exaly  

A Case of Heatstroke with Elevated CA19-9

Clinical Laboratory, 2017
Nan Wang, Tongtong Liu, Yu Wang, Xiaohong Chen   +3 more
openaire   +1 more source